France Branched Stent Grafts Market Size & Outlook
France branched stent grafts market, 2021-2028 (US$M)
Related Markets
France branched stent grafts market highlights
- The France branched stent grafts market generated a revenue of USD 6.8 million in 2021 and is expected to reach USD 11.7 million by 2028.
- The France market is expected to grow at a CAGR of 8.1% from 2022 to 2028.
- In terms of segment, iliac stent was the largest revenue generating type in 2021.
- Iliac Stent is the most lucrative type segment registering the fastest growth during the forecast period.
Branched stent grafts market data book summary
| Market revenue in 2021 | USD 6.8 million |
| Market revenue in 2028 | USD 11.7 million |
| Growth rate | 8.1% (CAGR from 2021 to 2028) |
| Largest segment | Iliac stent |
| Fastest growing segment | Iliac Stent |
| Historical data | 2021 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Iliac Stent |
| Key market players worldwide | Medtronic PLC, BIOTRONIK, Merit Medical Systems Inc, Abbott Laboratories, Cook Medical, Cardinal Health Inc, Boston Scientific Corp, Terumo Corp |
Other key industry trends
- In terms of revenue, France accounted for 2.4% of the global branched stent grafts market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, UK branched stent grafts market is projected to lead the regional market in terms of revenue in 2028.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 14.5 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Branched Stent Grafts Market Scope
Branched Stent Grafts Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France branched stent grafts market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to branched stent grafts market will help companies and investors design strategic landscapes.
Iliac stent was the largest segment with a revenue share of 39.71% in 2021. Horizon Databook has segmented the France branched stent grafts market based on iliac stent covering the revenue growth of each sub-segment from 2021 to 2028.
Major factors likely to drive the market growth in the country include rising demand for invasive treatment and growing awareness about vascular diseases. According to the data published by Knoema, 20.8% of the total population in the country was aged 65 and above in 2020.
According to the study published in National Library of Medicine, in France, the AAA treatment increased overall by 28.2% (from 6,412 procedures in 2006 to 8,221 in 2015). There was a substantial increase in the number of endovascular procedures, which became largely predominant in 2015 in France.
Reasons to subscribe to France branched stent grafts market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France branched stent grafts market databook
-
Our clientele includes a mix of branched stent grafts market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France branched stent grafts market , including forecasts for subscribers. This country databook contains high-level insights into France branched stent grafts market from 2021 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
France branched stent grafts market size, by type, 2021-2028 (US$M)
France Branched Stent Grafts Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
